# Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

> **NCT00034333** · PHASE2,PHASE3 · TERMINATED · sponsor: **FeRx** · enrollment: 240 (—)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** MTC-DOX for Injection

## Key facts

- **NCT ID:** NCT00034333
- **Lead sponsor:** FeRx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 240 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00034333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00034333, "Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00034333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*